Search results for "Occult"

showing 10 items of 92 documents

Faecal immunochemical tests: A valuable tool for colorectal cancer screening

2012

Colorectal cancer is a major health problem in industrialized ountries and fulfils the conditions required to justifymass screenng of the general population. Population-based controlled studies erformed in Europe have shown that guaiac faecal occult blood esting (G-FOBT) followed by colonoscopy to detect the cause of leeding can reduce colorectal cancer mortality [1]. Nearly all pubished studies evaluated the Hemoccult II (Beckman Coulter Inc., ea, USA) faecal occult blood test. Screening for colorectal caner using FOBT has, therefore, been included in the European Code gainst Cancer and has been endorsed by the European Commision [2]. Despite its high specificity, Hemoccult has been critic…

AdenomaMalemedicine.medical_specialtyColorectal cancerPopulationColonoscopyImmunologic TestsControlled studiesInternal medicinemedicineHumanseducationBlood testingEarly Detection of Cancereducation.field_of_studyHepatologymedicine.diagnostic_testbusiness.industryGastroenterologyCancerFaecal occult bloodmedicine.diseaseColorectal cancer screeningOccult BloodFemaleColorectal NeoplasmsbusinessDigestive and Liver Disease
researchProduct

Comparison of the yield from two faecal immunochemical tests at identical cutoff concentrations – a randomized trial in Latvia

2016

OBJECTIVE We have compared the performance of two faecal immunochemical tests (FIT) in an average-risk population. MATERIALS AND METHODS Altogether, 10 000 individuals aged 50-74 were selected randomly from the population of Latvia in 2011 and assigned randomly either to OC-Sensor or to FOB Gold single-time testing. Positivity of the test, frequency of colonic lesions, number needed to screen (NNscreen) and scope for the detection of an advanced neoplasm (cancer and advanced adenoma) were compared between the tests using the same cutoff concentrations in µg/g faeces. Confidence intervals (CIs) at 95% were calculated. RESULTS Positivity with the cutoff set at 10 µg/g faeces was 12.8% (95% CI…

AdenomaMalemedicine.medical_specialtyPopulationColonoscopyGastroenterologylaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialPredictive Value of TestslawInternal medicineHumansMass ScreeningMedicineCutoffeducationFecesAgededucation.field_of_studyHepatologymedicine.diagnostic_testbusiness.industryGastroenterologyReproducibility of ResultsColonoscopyMiddle AgedImmunohistochemistryLatviaNumber needed to screenConfidence intervalOccult Blood030220 oncology & carcinogenesisPredictive value of testsFemale030211 gastroenterology & hepatologyColorectal NeoplasmsbusinessEuropean Journal of Gastroenterology & Hepatology
researchProduct

Can the serological status of anti-HBc alone be considered a sentinel marker for detection of occult HBV infection?

2008

Some individuals have “occult” infection with hepatitis B virus (HBV), defined as presence of HBV genome in the serum or liver tissue without HBV surface antigen (HBsAg) in the serum. The aim of this study was to investigate whether serum antibodies against HBV core antigen in isolation (“anti-HBc alone”) are a useful marker of “occult” HBV in patients with or without hepatitis C virus (HCV) infection. “Anti-HBc alone” was detected in the sera of 119/6,544 (1.8%) asymptomatic outpatients referred to the diagnostic laboratory for routine testing for viral hepatitis, 62/607 (10.2%) drug users, and 42/195 (21.5%) patients with hepatocellular carcinoma. Using three in-house nested-PCR amplifica…

AdultMaleHBV serologic markerHBsAgHepatitis B virusGenotypeHepatitis C virusHBV genotypemedicine.disease_causeSettore MED/42 - Igiene Generale E ApplicataPolymerase Chain ReactionSensitivity and Specificity‘‘occult’’ HBVSerologyOrthohepadnavirusVirologymedicinePrevalenceHumansSerologic TestsHCCAgedHepatitis B virusAged 80 and overbiologybusiness.industryvirus diseasesSequence Analysis DNAHepatitis C AntibodiesMiddle Agedbiology.organism_classificationmedicine.diseaseHepatitis BVirologyHepatitis B Core AntigensHepatitis Cdigestive system diseasesInfectious DiseasesHepadnaviridaeImmunologyDNA Viralanti-HBcFemaleViral diseasebusinessViral hepatitisSentinel Surveillance
researchProduct

Occult Hepatitis B Infection in the Immigrant Population of Sicily, Italy.

2012

In Italy, about 7 % of the resident population is represented by immigrants originating from geographic regions at high endemicity for hepatitis B virus infection. This study aims to assess the prevalence of occult HBV infection (OBI) including the identification of HBV-genotypes in a population of immigrants serologically negative for hepatitis B surface antigen (HBsAg). Between May 2006 and May 2010, 339 immigrants were tested for markers of HBV, hepatitis C virus (HCV) and human immunodeficiency virus (HIV) infections. HBV-DNA was tested by using nested-PCR assays on three different genetic region. HBV-DNA was detected in plasma samples of 11/339 (3.2 %) patients. Most of them had no ser…

AdultMaleHBsAgHepatitis B virusSettore MED/09 - Medicina InternaHIV PositivityGenotypeSettore MED/17 - Malattie InfettiveEpidemiologyHepatitis C virusPopulationEmigrants and Immigrantsmedicine.disease_causeSettore MED/42 - Igiene Generale E ApplicataSerologyYoung AdultGenotypeHIV SeropositivitymedicinePrevalenceHumanseducationSicilyRetrospective StudiesHepatitis B viruseducation.field_of_studyHepatitis B Surface AntigensMolecular epidemiologybusiness.industryPublic Health Environmental and Occupational Healthvirus diseasesOccult HBV infection – Italy – HBV genotype – Immigrants – Molecular epidemiologyMiddle AgedHepatitis BVirologydigestive system diseasesCross-Sectional StudiesImmunologyDNA ViralFemalebusiness
researchProduct

Occult hepatitis B virus in liver tissue of individuals without hepatic disease

2008

Abstract BACKGROUND/AIMS: While many data are available concerning occult hepatitis B virus (HBV) infection in patients with hepatic disorders, there is little information about this cryptic infection in individuals without liver disease. The aim of this study was to investigate the prevalence of occult HBV in the general population by examining liver specimens from a large series of HBV-surface-antigen negative individuals with no clinical and biochemical evidence of liver disease. METHODS: The presence of HBV DNA was evaluated by testing, through polymerase chain reaction techniques, DNA extracts from 98 liver-disease-free individuals who underwent liver resection or needle biopsy during …

AdultMaleHepatitis B virusHBsAgHepatitis C virusPopulationhepatitis B virus liver tissuemedicine.disease_causeLiver diseaseNormal liverOrthohepadnavirusOccult HBVOccult HBV; HBV DNA; Normal liver; Anti-HBc; HBV-seronegativemedicineHumansHBV-seronegativeHepatitis B AntibodieseducationAgedHepatitis B viruseducation.field_of_studyHepatologybiologybusiness.industryvirus diseasesMiddle AgedHepatitis Bmedicine.diseasebiology.organism_classificationHepatitis B Core AntigensOccultdigestive system diseasesLiverHepadnaviridaeHBV DNACarrier StateDNA ViralImmunologyFemalebusinessAnti-HBcJournal of Hepatology
researchProduct

No detection of occult HBV-DNA in patients with various rheumatic diseases treated with anti-TNF agents: a two-year prospective study.

2013

OBJECTIVES: The widespread use of tumour necrosis factor (TNF)-targeted therapies in patients with rheumatic, digestive and dermatologic diseases has been associated with reports of reactivation of HBV replication and ensuing hepatitis flares both in asymptomatic HBsAg carriers and in subjects with occult HBV infection. The aim of our work was to investigate in a two-year prospective study the potential for HBV reactivation in patients with inflammatory joint diseases undergoing anti-TNF treatment from a southern Mediterranean area. METHODS: Fifty-seven consecutive outpatients attending the Academic Unit of Rheumatology at the University of Palermo (12 with rheumatoid arthritis, 17 with pso…

AdultMaleHepatitis B virusTime Factorsoccult HBV-DNAAntiviral AgentsPolymerase Chain ReactionRisk AssessmentRisk FactorsRheumatic Diseasesoccult HBV-DNA rheumatic diseases anti-TNFHumansProspective Studiesrheumatic diseaseAcademic Medical CentersHepatitis B Surface AntigensTumor Necrosis Factor-alphavirus diseasesanti-TNFMiddle AgedHepatitis Bdigestive system diseasesTreatment OutcomeItalyLamivudineAntirheumatic AgentsDNA ViralFemaleVirus ActivationBiomarkers
researchProduct

Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C

2003

Occult HBV infection in subjects with chronic hepatitis C is related to more severe disease outcome. It has been suggested that it might reduce sensitivity to antiviral treatment.To assess in HBsAg negative subjects with chronic hepatitis C any effect of the presence of HBV genomes in the liver on the early kinetics of HCV-RNA under PEG-IFN plus ribavirin.Twenty-two anti-HCV and HCV-RNA positive subjects, with biopsy-proven chronic hepatitis C (M/F 15/7; 50 +/- 8.6 years, 16 genotype 1b) were given PEG-IFN alpha 2b 1.0 microg qw plus ribavirin (800 to 1,200 mg daily according to body weight) for an intended 52 week period. Early virological response was assessed over the first 4 weeks of th…

AdultMaleHepatitis B viruspegylated interferon-alphaGenotypeBiopsyHepacivirusInterferon alpha-2Virus ReplicationAntiviral AgentsPolyethylene GlycolsHepatitis B AntibodieRibavirinchronic hepatitis CHumansHepatitis B AntibodiesAntiviral AgentHepaciviruoccult HBV infection; chronic hepatitis C; pegylated interferon-alpha; viral dynamics; treatment responseoccult HBV infectiontreatment responseInterferon-alphaAlanine TransaminaseHepatitis B viruHepatitis C AntibodiesHepatitis C ChronicMiddle AgedRecombinant ProteinViral LoadHepatitis Bviral dynamicsRecombinant ProteinsTreatment OutcomeLiverDNA ViralRNA ViralDrug Therapy CombinationFemaleHepatitis C AntibodieHuman
researchProduct

Prevalence of Occult Hepatitis B Virus Infection in a Cohort of HIV-Positive Patients Resident in Sicily, Italy

2013

Occult hepatitis B virus (OBI) in HIV-infected groups is still debated, as well as the associated risk-factors and clinical significance. In this paper, we examined a total of 405 HBsAg-negative/HIV-infected patients enrolled from January 2007 to December 2009. Overall, the prevalence of OBI was 5.9% (95% confidence interval (CI95%): 3.8–8.7%); it was more frequently associated with “anti-HBc alone” serological marker (11.3%; adjusted odds ratio = 3.7, CI95%: 1.4–9.8), although it was also detected in the absence of any HBV serological marker (4.9%; CI95%: 2.3–9.1%). A low prevalence of anti-HCV-positive patients with OBI was found (3.1%; CI95%: 0.6–8.7%). HIV RNA plasma levels or other imm…

AdultMaleOccult HBV HIV Prevalence Sicily Italymedicine.medical_specialtyHepatitis B virusArticle Subjectlcsh:MedicineHIV Infectionsmedicine.disease_causeSettore MED/42 - Igiene Generale E ApplicataGeneral Biochemistry Genetics and Molecular BiologySerologyInternal medicineGenotypemedicinePrevalenceHumansClinical significanceSicilyDemographyHepatitis B virusHepatitis B Surface AntigensGeneral Immunology and Microbiologybusiness.industrylcsh:Rvirus diseasesGeneral MedicineOdds ratioHepatitis Bmedicine.diseaseHepatitis BOccultdigestive system diseasesCohortImmunologyClinical StudyFemalebusiness
researchProduct

Detection of human immunodeficiency virus-1 DNA, RNA and antibody, and occult blood in inactivated saliva: Availability of the filter paper disk meth…

1996

Eighty three samples of saliva were collected from 60 subjects who were asymptomatic carriers of AIDS related complex (ARC) and AIDS. They included hemophiliacs, homosexuals and heterosexuals. Occult blood, human immunodeficiency virus-1 (HIV-1) antibody and DNA were assayed after heat treatment at 56 degrees C by strip method, particle agglutination and polymerase chain reaction (PCR), respectively. HIV-1 RNA was assayed by reverse transcription (RT)-PCR after heat treatment at 56 degrees C or 90 degrees C, or after application to filter paper disks with drying and heat treatment at 90 degrees C. Positive results were found in 53% (occult blood), 73% (HIV-1 antibody), 23% (HIV-1 DNA, 56 de…

AdultMaleSalivaAIDS-related complexHIV InfectionsBiologyPolymerase Chain Reactionlaw.inventionchemistry.chemical_compoundAIDS-Related ComplexRisk FactorslawHIV SeropositivitymedicineHumansChildSalivaPolymerase chain reactionAgedAcquired Immunodeficiency SyndromeAIDS SerodiagnosisInfantvirus diseasesRNAmedicine.diseaseVirologyMolecular biologyReverse transcriptaseReverse transcription polymerase chain reactionchemistryOccult BloodDNA ViralPediatrics Perinatology and Child HealthHIV-1biology.proteinRNA ViralFemaleAntibodyDNAPediatrics International
researchProduct

Sacral spina bifida occulta rare occurrence in Byzantine Belentepe population in Muğla, Turkey: A possible case for adequate folic acid intake.

2018

Spina bifida may occur during the first weeks after conception; folic acid deficiency is strongly related to this anomaly. We argue that the low prevalence rate of spina bifida may indicate a relatively good nutrition state of a population, given that folic acid is found in many food products commonly eaten. The aim of this study is to examine the relationship between folic acid intake and spina bifida occulta prevalence in the Belentepe Byzantine population in Anatolian peninsula, and to compare the prevalence rates with various other ancient Anatolian populations by focusing on sacral spina bifida occulta in the Byzantine population. A total of 62 available human sacra were included in th…

AdultMalecongenital hereditary and neonatal diseases and abnormalitiesSacrumAdolescentTurkeyPopulationPrevalenceNutritional StatusBiologyFolic Acid DeficiencySpina Bifida OccultaAnthropology PhysicalSpina bifida occultaYoung AdultmedicineHumanseducationChildHistory Ancienteducation.field_of_studySpina bifidaInfant NewbornInfantNutritional statusMiddle Agedmedicine.diseaseHistory Medievalnervous system diseasesFolic acidAnthropologyFood productsChild PreschoolFolic acid intakeFemaleByzantiumDemographyHomo : internationale Zeitschrift fur die vergleichende Forschung am Menschen
researchProduct